2024-11-14T06:35:17-06:00 2023-12-31 521073331 DEMBO JONES PC 6116 EXECUTIVE BLVD SUITE 500 NORTH BETHESDA MD 20852 990 2023-01-01 300283980 DINORA INC DINO 2022447422 3119 51ST PL NW WASHINGTON DC 200162639 VALORIE THOMPSON PRESIDENT 2022447422 2024-11-07 1 0 CHERYL D FINKELSTEIN CPA P01439227 3017705100 2023 2024-10-15 13:58:12Z VALORIE THOMPSON 3119 51ST PLACE NW WASHINGTON DC 20016 225980 0 X N/A X 2004 DC TO SUPPORT CHARITABLE AND EDUCATIONAL ACTIVITIES THAT PROMOTE THE CLINICAL APPLICATION OF UNIQUE THEORIES AND THERAPIES TO TREAT, PREVENT AND CURE ARTHRITIS THROUGH FUNDING STUDIES, EDUCATIONAL SEMINARS & MEDICAL PUBLICATIONS THAT PROMOTE NEW THERAPIES & TREATMENT 2 1 0 0 0 0 0 0 70000 225906 74 74 0 0 70074 225980 0 0 0 0 0 0 0 0 0 31021 172119 31021 172119 39053 53861 882021 935882 1084 1084 880937 934798 X TO SUPPORT CHARITABLE AND EDUCATIONAL ACTIVITIES THAT PROMOTE THE CLINICAL APPLICATION OF UNIQUE THEORIES AND THERAPIES TO TREAT, PREVENT AND CURE ARTHRITIS THROUGH FUNDING STUDIES EDUCATIONAL SEMINARS AND MEDICAL PUBLICATIONS THAT PROMOTE NEW THERAPIES AND TREATMENT 0 0 15050 4000 MYOSITIS WORKING GROUP - THE OMERACT MYOSITIS WORKING GROUP IS AN INTERNATIONAL COLLABORATION OF WELL-KNOWN CLINICAL RESEARCHERS, PATIENTS, AND STATISTICIANS. THE AIM OF THE WORKING GROUP IS TO DEVELOP OUTCOME MEASURES BASED ON PATIENTS' EXPERIENCES AND TO VALIDATE THESE MEASURES THOROUGHLY TO USE IN CLINICAL TRIALS. 43195 43195 INTERNATIONAL RHEUMATOLOGY COLLEAGUES DINNER - INITIATED IN 2000, THE IRC DINNER PROVIDES THE OPPORTUNITY FOR RHEUMATOLOGISTS TO BECOME UPDATED ON CURRENT CLINICAL RESEARCH ACTIVITIES. GIVEN THE RANGE OF RHEUMATOLOGIC DISORDERS, AND THE EVER-INCREASING NUMBER OF DIAGNOSTIC PROCEDURES AND TREATMENT OPTIONS, IT IS IMPORTANT TO PROVIDE CLINICIANS WITH INFORMATION TO UTILIZE THE MOST EFFECTIVE TREATMENTS TO ENSURE OPTIMAL PATIENT OUTCOMES. IT IS ALSO IMPORTANT FOR CLINICIANS AND RESEARCHERS TO ENHANCE THEIR KNOWLEDGE OF RESEARCH CURRENTLY BEING CONDUCTED AND THE BREAKTHROUGHS IN UNDERSTANDING THE UNDERLYING PATHOPHYSIOLOGY OF VARIOUS RHEUMATIC DISEASES WHICH MAY LEAD TO THE AVAILABILITY OF NEW TARGETED THERAPIES. 41708 109991 PROACTIVE - INITIATING AND SUPPORTING A PUBLIC PRIVATE, PRE-COMPETITIVE COLLABORATION AMONG A BROAD SPECTRUM OF STAKEHOLDERS, INCLUDING ACADEMIA, GOVERNMENT AGENCIES, INDUSTRY, PROFESSIONAL ORGANIZATIONS, AND PATIENT ORGANIZATIONS WITH THE GOAL OF SHARING DATA AND INNOVATIVE THINKING ABOUT THE DEVELOPMENT OF OSTEOARTHRITIS (OA) OUTCOME MEASURES FOR CLINICAL TRIALS OF THERAPIES AIMED AT SLOWING OA PROGRESSION.THE FOOD AND DRUG ADMINISTRATION APPROVED PROACTIVE'S APPLICATION SEEKING PARTICIPATION BY INDIVIDUALS FROM THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) TO ENGAGE IN THE ACTIVITIES OF THE CONSORTIUM. 68720 68720 MULTIDISCIPLINARY MEETING (RHEUMATOLOGISTS/NEPHROLOGISTS) TO REVIEW DATA ON THE USE OF IMMUNOMODULATORS IN CHRONIC GOUT PATIENTS WITH RENOVASCULAR COMORBIDITIES; PUBLICATION BASED ON MEETING PROCEEDINGS 68720 68720 168673 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 2 1 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 1 0 0 0 DC X THE ORGANIZATION 2022447422 3119 51ST PL NW WASHINGTON DC 200162639 X VALORIE THOMPSON DIRECTOR 1.00 X X 0 0 0 ANTHONY A SARIDAKIS SECRETARY/TREASURER 1.00 X X 0 0 0 0 0 0 0 0 0 0 0 PROACTIVE SPONORSHIP 541900 109991 109991 GOUT MEETING GRANT 541900 68720 68720 IRC ANNUAL DINNER GRAN 541900 43195 43195 MYOSITIS WORKING GROUP 541900 4000 4000 225906 74 74 225980 225906 0 74 1350 1350 599 599 11883 11883 1417 1417 GOUT MEETING 68720 68720 INTERNATIONAL RHEUMATOL 43195 43195 PROACTIVE 29825 29825 OMERACT EXPENSE 15050 15050 80 80 172119 168673 3446 0 882021 935882 882021 935882 1084 1084 1084 1084 X 880937 934798 880937 934798 882021 935882 53861 0 X 0 0 0 X 404115 5000 151000 70000 225906 856021 404115 5000 151000 70000 225906 856021 0 0 0 856021 3753 288 74 74 74 4263 3753 288 74 74 74 4263 407868 5288 151074 70074 225980 860284 0.99500 0.99450 0.00500 0.00550 X VALORIE THOMPSON DIRECTOR OF DINORA INNOVATIONS CONSULTING GROUP PROVIDES SERVICES TO DINORA. X 1084 1084 0 1 0 1084 FORM 990, PART VI, SECTION A, LINE 8B DINORA HAS NO COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE BOARD ELECTRONICALLY BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY FOR PURPOSES OF THIS PROVISION, THE TERM "INTEREST" SHALL INCLUDE PERSONAL INTEREST, INTEREST AS DIRECTOR, OFFICER, TRUSTEE OR BENEFICIARY OF ANY CONCERN AND HAVING AN IMMEDIATE FAMILY MEMBER WHO HOLDS SUCH AN INTEREST IN ANY CONCERN. THE TERM "CONCERN" SHALL MEAN ANY CORPORATION, ASSOCIATION, TRUST, PARTNERSHIP, LIMITED LIABILITY ENTITY, FIRM, PERSON OR OTHER ENTITY OTHER THAN THE ORGANIZATION. NO DIRECTOR OR OFFICER OF THE ORGANIZATION SHALL BE DISQUALIFIED FROM HOLDING ANY OFFICE IN THE ORGANIZATION BY REASON OF ANY INTEREST IN ANY CONCERN. A DIRECTOR OR OFFICER OF THE ORGANIZATION SHALL NOT BE DISQUALIFIED FROM DEALING, EITHER AS VENDOR, PURCHASER OR OTHERWISE, OR CONTRACTING OR ENTERING INTO ANY OTHER TRANSACTION WITH THE ORGANIZATION OR WITH ANY ENTITY OF WHICH THE ORGANIZATION IS AN AFFILIATE NO TRANSACTION OF THE ORGANIZATION SHALL BE VOIDABLE BY REASON OF THE FACT THAT ANY DIRECTOR OR OFFICER OF THE ORGANIZATION HAS AN INTEREST IN THE CONCERN WITH WHICH SUCH TRANSACTION IS ENTERED INTO, PROVIDED THE INTEREST OF SUCH OFFICER OR DIRECTOR IS FULLY DISCLOSED TO THE BOARD OF DIRECTORS SUCH TRANSACTIONS IS DULY APPROVED BY THE BOARD OF DIRECTORS NOT SO INTERESTED OR CONNECTED AS BEING IN THE BEST INTERESTS OF THE ORGANIZATION. PAYMENTS TO THE INTERESTED OFFICER OR DIRECTOR ARE REASONABLE AND DO NOT EXCEED FAIR MARKET VALUE. NO INTERESTED OFFICER OR DIRECTOR MAY VOTE OR LOBBY ON THE MATTER OR BE COUNTED IN DETERMINING THE EXISTENCE OF A QUORUM AT THE MEETING AT WHICH SUCH TRANSACTION MAY BE AUTHORIZED. THE MINUTES OF MEETINGS WHICH SUCH VOTES ARE TAKEN SHALL RECORD SUCH DISCLOSURE, ABSTENTION, AND RATIONALE FOR APPROVAL. FORM 990, PART VI, SECTION C, LINE 18 THE ORGANIZATION MAKES ITS FORM 990 AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST AND THROUGH WWW.GUIDESTAR.COM FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.